​

89bio (ETNB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

89bio Revenue Highlights

00

89bio Revenue by Period

89bio Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

89bio generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

89bio Revenue by Quarter

DateRevenueChange
2025-03-31--100.00%
2024-12-31$21.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$234.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30--

89bio generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

89bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
GLPGGalapagos$239.70M$62.43M
TVTXTravere Therapeutics$233.18M$114.45M
RXRXRecursion Pharmaceuticals$58.84M$19.22M
AGIOAgios Pharmaceuticals$36.50M$12.46M
IBRXImmunityBio$14.74M$26.43M
MESOMesoblast$7.50M$1.69M
IDYAIDEAYA Biosciences$7.00M-
ETNB89bio--
COGTCogent Biosciences--
DYNDyne Therapeutics--
DNLIDenali Therapeutics--

ETNB Revenue FAQ

What is 89bio’s yearly revenue?

89bio's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. ETNB's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is 89bio’s quarterly revenue?

89bio's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $21K, a 100.00% increase from the previous quarter (Q3 2024), and a -91.03% decrease year-over-year (Q4 2023). ETNB's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023).

What is 89bio’s revenue growth rate?

89bio's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.